Skip to main content
. 2021 May 19;12:687549. doi: 10.3389/fphar.2021.687549

TABLE 3.

Sensitivity analysis of the effect of different lengths of treatment gap period defining non-persistence.

Treatment gap to define non-persistence (months)
1 2 3 4 5 6 12
Non-persistent patients
1st year 3,897 (42.5) 2,861 (31.2) 2,187 (23.8) 1,804 (19.7) 1,524 (16.6) 1,350 (14.7) 832 (9.1)
2nd year 844 (9.2) 782 (8.5) 780 (8.5) 770 (8.4) 729 (7.9) 670 (7.3) 552 (6.0)
3rd year 333 (3.6) 445 (4.9) 476 (5.2) 498 (5.4) 493 (5.4) 498 (5.4) 441 (4.8)
4th year 190 (2.1) 296 (3.2) 340 (3.7) 333 (3.6) 346 (3.8) 353 (3.8) 344 (3.7)
5th year 140 (1.5) 221 (2.4) 223 (2.4) 202 (2.2) 194 (2.1) 161 (1.8) 18 (0.2)
Total 5,404 (58.9) 4,605 (50.2) 4,006 (43.6) 3,607 (39.3) 3,286 (35.8) 3,032 (33.0) 2,187 (23.8)

Values represent the frequency, and the percentages are provided in parentheses (% of n = 9,178).